Catalog No.
YVV23401
Expression system
E. coli
Species
Influenza A virus (strain A/Puerto Rico/8/1934 (H1N1))
Protein length
[Ser2-Ser22] & [Asp44-Glu97]
Predicted molecular weight
37.10 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P06821
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Matrix protein 2, Proton channel protein M2, M
Understanding the Molecular Interactions Between Influenza A Virus and Streptococcus Proteins in Co-Infection: A Scoping Review., PMID:40005491
Molecular characterization of the whole genome of H9N2 avian influenza virus isolated from Egyptian poultry farms., PMID:38625394
High-Yield Production of Chimeric Hepatitis E Virus-Like Particles Bearing the M2e Influenza Epitope and Receptor Binding Domain of SARS-CoV-2 in Plants Using Viral Vectors., PMID:36555326
Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic., PMID:35399819
Combination of conserved recombinant proteins (NP & 3M2e) formulated with Alum protected BALB/c mice against influenza A/PR8/H1N1 virus challenge., PMID:34491470
Calcitriol [1, 25[OH]2 D3] pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells., PMID:23015061
Genetic evolution of low pathogenecity H9N2 avian influenza viruses in Tunisia: acquisition of new mutations., PMID:21992186
Anti-influenza virus activity of tricin, 4',5,7-trihydroxy-3',5'-dimethoxyflavone., PMID:21860068
Detection of pandemic influenza A/H1N1/2009 virus by real-time reverse transcription polymerase chain reaction., PMID:19963010
Simultaneous one-tube full-length amplification of the NA, NP, M, and NS genes of influenza A viruses for reverse genetics., PMID:19406155
Reconstruction of a chicken BF2 protein complex and identification of binding nonamer peptides derived from avian influenza virus hemagglutinin., PMID:18687473
A fully automated procedure for the high-throughput detection of avian influenza virus by real-time reverse transcription-polymerase chain reaction., PMID:17494559
Cell-specific inhibition of paramyxovirus maturation by proteasome inhibitors., PMID:16172538
Cross-reactive protection against influenza A virus by a topically applied DNA vaccine encoding M gene with adjuvant., PMID:16035949
Interaction between an amantadine analogue and the transmembrane portion of the influenza A M2 protein in liposomes probed by 1H NMR spectroscopy of the ligand., PMID:15369403
Structure of a knockout mutant of influenza virus M1 protein that has altered activities in membrane binding, oligomerisation and binding to NEP (NS2)., PMID:14749176
Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity., PMID:14732346
Studies of structural changes in the M2 proton channel of influenza A virus by tryptophan fluorescence., PMID:14687947
Viroporins., PMID:12972148
Membrane peptides and their role in protobiological evolution., PMID:12967266
The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses., PMID:12954218
Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA., PMID:12745578
Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2., PMID:12744898
Nuclear export of influenza viral ribonucleoprotein is temperature-dependently inhibited by dissociation of viral matrix protein., PMID:12642098
N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication., PMID:12628550
Influenza B virus BM2 protein is an oligomeric integral membrane protein expressed at the cell surface., PMID:12620792
Zinc- and pH-dependent conformational transition in a putative interdomain linker region of the influenza virus matrix protein M1., PMID:12590584
Induction of antigen-specific CTL by recombinant HIV trans-activating fusion protein-pulsed human monocyte-derived dendritic cells., PMID:12538688
The closed state of a H+ channel helical bundle combining precise orientational and distance restraints from solid state NMR., PMID:12403618
A functional link between the actin cytoskeleton and lipid rafts during budding of filamentous influenza virions., PMID:12359424
Selective translation of eukaryotic mRNAs: functional molecular analysis of GRSF-1, a positive regulator of influenza virus protein synthesis., PMID:12239318
Influenza A virus with defective M2 ion channel activity as a live vaccine., PMID:12202229
Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus., PMID:12124449
Aggregation of influenza virus ribonucleocapsids at low pH., PMID:12034481
Exploitation of the Herpes simplex virus translocating protein VP22 to carry influenza virus proteins into cells for studies of apoptosis: direct confirmation that neuraminidase induces apoptosis and indications that other proteins may have a role., PMID:12021867
[Emergence of amantadine-resistant influenza A viruses]., PMID:11977753
Conditional ablation of T-cell development by a novel viral ion channel transgene., PMID:11918692
Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis., PMID:11773396
Detection of amantadine-resistant influenza A virus strains in nursing homes by PCR-restriction fragment length polymorphism analysis with nasopharyngeal swabs., PMID:11773097
Effect of influenza virus matrix protein and viral RNA on ribonucleoprotein formation and nuclear export., PMID:11531417
Transport of viral proteins to the apical membranes and interaction of matrix protein with glycoproteins in the assembly of influenza viruses., PMID:11451488
Nuclear export of influenza virus ribonucleoproteins: identification of an export intermediate at the nuclear periphery., PMID:11289803
Definitive assignment of proton selectivity and attoampere unitary current to the M2 ion channel protein of influenza A virus., PMID:11264354
Genomic analysis of matrix gene and antigenic studies of its gene product (M1) of a swine influenza virus (H1N1) causing chronic respiratory disease in pigs., PMID:11129631
Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan., PMID:11128067
Use of a single glycine residue to determine the tilt and orientation of a transmembrane helix. A new structural label for infrared spectroscopy., PMID:11106618
Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation., PMID:11058576
Analysis of the pore structure of the influenza A virus M(2) ion channel by the substituted-cysteine accessibility method., PMID:10933681
Transmembrane domain of M2 protein from influenza A virus studied by solid-state (15)N polarization inversion spin exchange at magic angle NMR., PMID:10920010
Permeation and activation of the M2 ion channel of influenza A virus., PMID:10913133